QuickMD Surpasses 2 Million Patient Visits

LOS ANGELES, October 13, 2026 /CourierPR/ -- QuickMD, the largest telemedicine provider of opioid use disorder care in the U.S., has surpassed 2 million patient visits, according to a recent press release. The company has more than 500,000 visits in 2026 so far, accounting for roughly one in every four visits in the company's history. This rapid growth follows a year of steady expansion, with QuickMD's platform now reaching patients in 44 states and Washington, D.C., more than any other direct-to-consumer addiction treatment telemedicine provider in the country.

The company has added more than 80 clinicians in the past six months, bringing its active network to nearly 200. QuickMD has also launched mental health care and introduced a dedicated plan for people seeking help quitting 7-OH and kratom. The company's addiction treatment visits cost $99, with no insurance or referral required, and same-day visits are often available seven days a week. Patients can book online, meet privately with a licensed clinician by phone or video, and have eligible prescriptions delivered to their homes through QuickMD's pharmacy partners.

Much of this momentum comes from making care easier to access, with QuickMD removing many of the barriers that prevent people from seeking the help they need.

QuickMD's rapid expansion has made it the largest U.S. telemedicine provider of opioid use disorder care by patient visits and geographic reach, with more than 2 million visits across 44 states and D.C. The company specializes in Medication-Assisted Treatment (MAT) for opioid use disorder and 7-OH and kratom dependence, and also offers women's hormone therapy, mental health care, weight management, and urgent care. Through its nationwide network of experienced clinicians, QuickMD helps patients get care quickly, wherever they are.